Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-013070

Chief Technology Officer sold 7,000 shares at an average $27.23 ($190,579)

  • Chief Technology Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myer Vickesh · Chief Technology Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-19 Exercise or conversion : show line 1 in the form +2,700 $0.65 $1,755 2,700 D
2018-11-19 Sale : show line 2 in the form −2,700 $28.12 $75,924 0 D
2018-11-19 Exercise or conversion : show line 3 in the form +300 $0.65 $195 300 D
2018-11-19 Sale : show line 4 in the form −300 $28.85 $8,655 0 D
2018-11-20 Exercise or conversion : show line 5 in the form +4,000 $11.21 $44,840 4,000 D
2018-11-20 Sale : show line 6 in the form −4,000 $26.50 $106,000 0 D
Open-market sales · 7,000 sh · avg $27.23 · $190,579

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-11-19 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −3,000 85,307 D
2018-11-20 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −4,000 60,897 D
Loading xslF345X03/edgar.xml…